--- title: "Liquid Biopsy Monitoring Study | Sutter Health" description: "A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung cancer." url: "https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Research studies](https://www.sutterhealth.org/research/studies) / 4. Liquid Biopsy Monitoring Study # Cancer Liquid Biopsy Monitoring Study Liquid biopsy is a test done on a sample of blood to examine pieces of DNA from tumor cells circulating in the blood (circulating tumor DNA, ctDNA). The detection of ctDNA in blood may be used to monitor treatment response, disease recurrence, and therapy resistance. This study seeks to provide evidence that liquid biopsy monitoring provides useful genomic information for oncologists to improve how they treat their patients. Researchers at Sutter Health are collecting serial blood samples from eligible patients with newly diagnosed metastatic melanoma or metastatic lung cancer to monitor ctDNA mutations as participants undergo treatment. All participants will have results from ctDNA testing provided to their treating physicians. ## Sub-Investigator [Mohammed Kashani-Sabet, M.D.](https://www.sutterhealth.org/research/investigators/mohammed-kashani-sabet-md-1049681175) ## Research topics - [All Cancer](https://www.sutterhealth.org/research-search-results?query=%22%5C%22All+Cancer%5C%22%22) ## Related studies [View all studies](https://www.sutterhealth.org/research/studies) - Research study ### [Bone Marrow Transplant Database](https://www.sutterhealth.org/research/studies/bone-marrow-transplant-1049141785) Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries - Research study ### [Adjuvant Advanced Cervical Cancer GY037](https://www.sutterhealth.org/research/studies/adjuvant-advanced-cervical-cancer-gy037-2092836140) A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer - Research study ### [Ductal Carcinoma In Situ (DCIS) Registry Dana Farber](https://www.sutterhealth.org/research/studies/dana-farber-13-09-259-dcis-1049141920) Molecular Characterization of Breast Cancer with Duct Forming Features - Research study ### [Melanoma DECIDE](https://www.sutterhealth.org/research/studies/melanoma-castle-decide-1049141954) DecisionDx-Melanoma Impact in Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes - Research study ### [Melanoma Follow Up R3767-ONC-2466](https://www.sutterhealth.org/research/studies/melanoma-follow-up-r3767-onc-2466-2059416020) Extended Follow-up of Patients With Melanoma Treated With Fianlimab Plus Cemiplimab in Expansion Cohorts From Study R3767-ONC-1613 [View all studies](https://www.sutterhealth.org/research/studies) ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research studies","item":"https://www.sutterhealth.org/research/studies"},{"@type":"ListItem","position":4,"name":"Liquid Biopsy Monitoring Study"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalWebPage","@id":"https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806#medicalwebpage","name":"Liquid Biopsy Monitoring Study","description":"A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung cancer.","url":"https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806","inLanguage":"en-US","dateModified":"2026-08-11","publisher":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"medicalAudience":{"@type":"Patient"},"mainEntity":{"@id":"https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806#medicalobservationalstudy"},"breadcrumb":{"@id":"https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806#breadcrumblist"},"mentions":[{"@type":"Person","@id":"https://www.sutterhealth.org/find-provider/dr-mohammed-kashanisabet-1046240531#Person","name":"Mohammed Kashani-Sabet, M.D.","url":"https://www.sutterhealth.org/research/investigators/mohammed-kashani-sabet-md-1049681175","sameAs":"https://www.sutterhealth.org/find-provider/dr-mohammed-kashanisabet-1046240531"}]} ``` ```json {"@context":"https://schema.org","@type":"MedicalObservationalStudy","@id":"https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806#medicalobservationalstudy","name":"Cancer Liquid Biopsy Monitoring Study","alternateName":"Liquid Biopsy Monitoring Study","url":"https://www.sutterhealth.org/research/studies/liquid-biopsy-monitoring-study-1049141806","description":"Liquid biopsy is a test done on a sample of blood to examine pieces of DNA from tumor cells circulating in the blood (circulating tumor DNA, ctDNA). The detection of ctDNA in blood may be used to monitor treatment response, disease recurrence, and therapy resistance. This study seeks to provide evidence that liquid biopsy monitoring provides useful genomic information for oncologists to improve how they treat their patients. Researchers at Sutter Health are collecting serial blood samples from eligible patients with newly diagnosed metastatic melanoma or metastatic lung cancer to monitor ctDNA mutations as participants undergo treatment. All participants will have results from ctDNA testing provided to their treating physicians.","healthCondition":[{"@type":"MedicalCondition","name":"All Cancer"}]} ```